nodes	percent_of_prediction	percent_of_DWPC	metapath
Methylscopolamine bromide—Dizziness—Vinblastine—hematologic cancer	0.00101	0.00134	CcSEcCtD
Methylscopolamine bromide—Insomnia—Alitretinoin—hematologic cancer	0.00101	0.00134	CcSEcCtD
Methylscopolamine bromide—Urticaria—Vinorelbine—hematologic cancer	0.00101	0.00134	CcSEcCtD
Methylscopolamine bromide—Constipation—Thalidomide—hematologic cancer	0.00101	0.00133	CcSEcCtD
Methylscopolamine bromide—Somnolence—Carmustine—hematologic cancer	0.00101	0.00133	CcSEcCtD
Methylscopolamine bromide—Asthenia—Hydroxyurea—hematologic cancer	0.001	0.00132	CcSEcCtD
Methylscopolamine bromide—Feeling abnormal—Thiotepa—hematologic cancer	0.001	0.00132	CcSEcCtD
Methylscopolamine bromide—Headache—Cladribine—hematologic cancer	0.001	0.00132	CcSEcCtD
Methylscopolamine bromide—Vision blurred—Prednisolone—hematologic cancer	0.000996	0.00131	CcSEcCtD
Methylscopolamine bromide—Somnolence—Alitretinoin—hematologic cancer	0.000996	0.00131	CcSEcCtD
Methylscopolamine bromide—Nausea—Chlorambucil—hematologic cancer	0.000994	0.00131	CcSEcCtD
Methylscopolamine bromide—Somnolence—Ifosfamide—hematologic cancer	0.000984	0.0013	CcSEcCtD
Methylscopolamine bromide—Insomnia—Vincristine—hematologic cancer	0.000976	0.00129	CcSEcCtD
Methylscopolamine bromide—Vomiting—Vinblastine—hematologic cancer	0.000975	0.00129	CcSEcCtD
Methylscopolamine bromide—Nausea—Nilotinib—hematologic cancer	0.000972	0.00128	CcSEcCtD
Methylscopolamine bromide—Feeling abnormal—Thalidomide—hematologic cancer	0.00097	0.00128	CcSEcCtD
Methylscopolamine bromide—Urticaria—Thiotepa—hematologic cancer	0.000967	0.00128	CcSEcCtD
Methylscopolamine bromide—Constipation—Carmustine—hematologic cancer	0.000967	0.00128	CcSEcCtD
Methylscopolamine bromide—Nausea—Imatinib—hematologic cancer	0.000967	0.00127	CcSEcCtD
Methylscopolamine bromide—Hypersensitivity—Bortezomib—hematologic cancer	0.000962	0.00127	CcSEcCtD
Methylscopolamine bromide—Headache—Vinblastine—hematologic cancer	0.000961	0.00127	CcSEcCtD
Methylscopolamine bromide—Constipation—Alitretinoin—hematologic cancer	0.000958	0.00126	CcSEcCtD
Methylscopolamine bromide—Anaphylactic shock—Cisplatin—hematologic cancer	0.000955	0.00126	CcSEcCtD
Methylscopolamine bromide—Hypersensitivity—Bleomycin—hematologic cancer	0.000955	0.00126	CcSEcCtD
Methylscopolamine bromide—Insomnia—Irinotecan—hematologic cancer	0.000951	0.00125	CcSEcCtD
Methylscopolamine bromide—Nausea—Cladribine—hematologic cancer	0.00095	0.00125	CcSEcCtD
Methylscopolamine bromide—Constipation—Ifosfamide—hematologic cancer	0.000947	0.00125	CcSEcCtD
Methylscopolamine bromide—Hypersensitivity—Vinorelbine—hematologic cancer	0.000939	0.00124	CcSEcCtD
Methylscopolamine bromide—Dizziness—Lenalidomide—hematologic cancer	0.000938	0.00124	CcSEcCtD
Methylscopolamine bromide—Asthenia—Bortezomib—hematologic cancer	0.000937	0.00124	CcSEcCtD
Methylscopolamine bromide—Urticaria—Thalidomide—hematologic cancer	0.000935	0.00123	CcSEcCtD
Methylscopolamine bromide—Somnolence—Mitoxantrone—hematologic cancer	0.000935	0.00123	CcSEcCtD
Methylscopolamine bromide—Somnolence—Irinotecan—hematologic cancer	0.000935	0.00123	CcSEcCtD
Methylscopolamine bromide—Feeling abnormal—Carmustine—hematologic cancer	0.000932	0.00123	CcSEcCtD
Methylscopolamine bromide—Tachycardia—Cisplatin—hematologic cancer	0.000932	0.00123	CcSEcCtD
Methylscopolamine bromide—Asthenia—Bleomycin—hematologic cancer	0.00093	0.00123	CcSEcCtD
Methylscopolamine bromide—Vomiting—Melphalan—hematologic cancer	0.000928	0.00122	CcSEcCtD
Methylscopolamine bromide—Insomnia—Gemcitabine—hematologic cancer	0.000926	0.00122	CcSEcCtD
Methylscopolamine bromide—Dizziness—Hydroxyurea—hematologic cancer	0.000925	0.00122	CcSEcCtD
Methylscopolamine bromide—Feeling abnormal—Alitretinoin—hematologic cancer	0.000923	0.00122	CcSEcCtD
Methylscopolamine bromide—Constipation—Vincristine—hematologic cancer	0.000923	0.00122	CcSEcCtD
Methylscopolamine bromide—Asthenia—Vinorelbine—hematologic cancer	0.000915	0.00121	CcSEcCtD
Methylscopolamine bromide—Feeling abnormal—Ifosfamide—hematologic cancer	0.000912	0.0012	CcSEcCtD
Methylscopolamine bromide—Nausea—Vinblastine—hematologic cancer	0.000911	0.0012	CcSEcCtD
Methylscopolamine bromide—Somnolence—Gemcitabine—hematologic cancer	0.00091	0.0012	CcSEcCtD
Methylscopolamine bromide—Vomiting—Lenalidomide—hematologic cancer	0.000902	0.00119	CcSEcCtD
Methylscopolamine bromide—Constipation—Mitoxantrone—hematologic cancer	0.000899	0.00119	CcSEcCtD
Methylscopolamine bromide—Constipation—Irinotecan—hematologic cancer	0.000899	0.00119	CcSEcCtD
Methylscopolamine bromide—Hypersensitivity—Thiotepa—hematologic cancer	0.000897	0.00118	CcSEcCtD
Methylscopolamine bromide—Urticaria—Alitretinoin—hematologic cancer	0.00089	0.00117	CcSEcCtD
Methylscopolamine bromide—Vomiting—Hydroxyurea—hematologic cancer	0.000889	0.00117	CcSEcCtD
Methylscopolamine bromide—Headache—Lenalidomide—hematologic cancer	0.000889	0.00117	CcSEcCtD
Methylscopolamine bromide—Confusional state—Etoposide—hematologic cancer	0.000882	0.00116	CcSEcCtD
Methylscopolamine bromide—Urticaria—Ifosfamide—hematologic cancer	0.00088	0.00116	CcSEcCtD
Methylscopolamine bromide—Headache—Hydroxyurea—hematologic cancer	0.000876	0.00116	CcSEcCtD
Methylscopolamine bromide—Constipation—Gemcitabine—hematologic cancer	0.000876	0.00115	CcSEcCtD
Methylscopolamine bromide—Anaphylactic shock—Etoposide—hematologic cancer	0.000874	0.00115	CcSEcCtD
Methylscopolamine bromide—Asthenia—Thiotepa—hematologic cancer	0.000873	0.00115	CcSEcCtD
Methylscopolamine bromide—Abdominal distension—Epirubicin—hematologic cancer	0.000868	0.00114	CcSEcCtD
Methylscopolamine bromide—Hypersensitivity—Thalidomide—hematologic cancer	0.000868	0.00114	CcSEcCtD
Methylscopolamine bromide—Nausea—Melphalan—hematologic cancer	0.000867	0.00114	CcSEcCtD
Methylscopolamine bromide—Feeling abnormal—Mitoxantrone—hematologic cancer	0.000866	0.00114	CcSEcCtD
Methylscopolamine bromide—Feeling abnormal—Irinotecan—hematologic cancer	0.000866	0.00114	CcSEcCtD
Methylscopolamine bromide—Dizziness—Bortezomib—hematologic cancer	0.000863	0.00114	CcSEcCtD
Methylscopolamine bromide—Anaphylactic shock—Prednisolone—hematologic cancer	0.000863	0.00114	CcSEcCtD
Methylscopolamine bromide—Tachycardia—Etoposide—hematologic cancer	0.000853	0.00113	CcSEcCtD
Methylscopolamine bromide—Erectile dysfunction—Methotrexate—hematologic cancer	0.000848	0.00112	CcSEcCtD
Methylscopolamine bromide—Asthenia—Thalidomide—hematologic cancer	0.000845	0.00111	CcSEcCtD
Methylscopolamine bromide—Feeling abnormal—Gemcitabine—hematologic cancer	0.000844	0.00111	CcSEcCtD
Methylscopolamine bromide—Dizziness—Vinorelbine—hematologic cancer	0.000843	0.00111	CcSEcCtD
Methylscopolamine bromide—Nausea—Lenalidomide—hematologic cancer	0.000843	0.00111	CcSEcCtD
Methylscopolamine bromide—Tachycardia—Prednisolone—hematologic cancer	0.000842	0.00111	CcSEcCtD
Methylscopolamine bromide—Urticaria—Mitoxantrone—hematologic cancer	0.000835	0.0011	CcSEcCtD
Methylscopolamine bromide—Hypersensitivity—Carmustine—hematologic cancer	0.000833	0.0011	CcSEcCtD
Methylscopolamine bromide—Nausea—Hydroxyurea—hematologic cancer	0.000831	0.0011	CcSEcCtD
Methylscopolamine bromide—Vomiting—Bortezomib—hematologic cancer	0.00083	0.00109	CcSEcCtD
Methylscopolamine bromide—Hypersensitivity—Alitretinoin—hematologic cancer	0.000825	0.00109	CcSEcCtD
Methylscopolamine bromide—Vomiting—Bleomycin—hematologic cancer	0.000824	0.00109	CcSEcCtD
Methylscopolamine bromide—Drowsiness—Methotrexate—hematologic cancer	0.000821	0.00108	CcSEcCtD
Methylscopolamine bromide—Headache—Bortezomib—hematologic cancer	0.000818	0.00108	CcSEcCtD
Methylscopolamine bromide—Hypersensitivity—Ifosfamide—hematologic cancer	0.000816	0.00108	CcSEcCtD
Methylscopolamine bromide—Asthenia—Carmustine—hematologic cancer	0.000811	0.00107	CcSEcCtD
Methylscopolamine bromide—Vomiting—Vinorelbine—hematologic cancer	0.000811	0.00107	CcSEcCtD
Methylscopolamine bromide—Dry mouth—Triamcinolone—hematologic cancer	0.000809	0.00107	CcSEcCtD
Methylscopolamine bromide—Dizziness—Thiotepa—hematologic cancer	0.000805	0.00106	CcSEcCtD
Methylscopolamine bromide—Asthenia—Alitretinoin—hematologic cancer	0.000804	0.00106	CcSEcCtD
Methylscopolamine bromide—Abdominal distension—Doxorubicin—hematologic cancer	0.000803	0.00106	CcSEcCtD
Methylscopolamine bromide—Headache—Vinorelbine—hematologic cancer	0.000799	0.00105	CcSEcCtD
Methylscopolamine bromide—Hypersensitivity—Vincristine—hematologic cancer	0.000795	0.00105	CcSEcCtD
Methylscopolamine bromide—Asthenia—Ifosfamide—hematologic cancer	0.000794	0.00105	CcSEcCtD
Methylscopolamine bromide—Anaphylactic shock—Triamcinolone—hematologic cancer	0.000793	0.00105	CcSEcCtD
Methylscopolamine bromide—Feeling abnormal—Cisplatin—hematologic cancer	0.000787	0.00104	CcSEcCtD
Methylscopolamine bromide—Insomnia—Prednisolone—hematologic cancer	0.00078	0.00103	CcSEcCtD
Methylscopolamine bromide—Dizziness—Thalidomide—hematologic cancer	0.000779	0.00103	CcSEcCtD
Methylscopolamine bromide—Somnolence—Etoposide—hematologic cancer	0.000777	0.00103	CcSEcCtD
Methylscopolamine bromide—Nausea—Bortezomib—hematologic cancer	0.000775	0.00102	CcSEcCtD
Methylscopolamine bromide—Hypersensitivity—Mitoxantrone—hematologic cancer	0.000775	0.00102	CcSEcCtD
Methylscopolamine bromide—Hypersensitivity—Irinotecan—hematologic cancer	0.000775	0.00102	CcSEcCtD
Methylscopolamine bromide—Asthenia—Vincristine—hematologic cancer	0.000775	0.00102	CcSEcCtD
Methylscopolamine bromide—Tachycardia—Triamcinolone—hematologic cancer	0.000774	0.00102	CcSEcCtD
Methylscopolamine bromide—Vomiting—Thiotepa—hematologic cancer	0.000774	0.00102	CcSEcCtD
Methylscopolamine bromide—Nausea—Bleomycin—hematologic cancer	0.00077	0.00101	CcSEcCtD
Methylscopolamine bromide—Drowsiness—Epirubicin—hematologic cancer	0.000769	0.00101	CcSEcCtD
Methylscopolamine bromide—Headache—Thiotepa—hematologic cancer	0.000763	0.00101	CcSEcCtD
Methylscopolamine bromide—Nausea—Vinorelbine—hematologic cancer	0.000757	0.000998	CcSEcCtD
Methylscopolamine bromide—Asthenia—Irinotecan—hematologic cancer	0.000754	0.000995	CcSEcCtD
Methylscopolamine bromide—Asthenia—Mitoxantrone—hematologic cancer	0.000754	0.000995	CcSEcCtD
Methylscopolamine bromide—Vomiting—Thalidomide—hematologic cancer	0.000749	0.000987	CcSEcCtD
Methylscopolamine bromide—Dizziness—Carmustine—hematologic cancer	0.000748	0.000986	CcSEcCtD
Methylscopolamine bromide—Constipation—Etoposide—hematologic cancer	0.000748	0.000986	CcSEcCtD
Methylscopolamine bromide—Dizziness—Alitretinoin—hematologic cancer	0.000741	0.000977	CcSEcCtD
Methylscopolamine bromide—Headache—Thalidomide—hematologic cancer	0.000738	0.000973	CcSEcCtD
Methylscopolamine bromide—Asthenia—Gemcitabine—hematologic cancer	0.000735	0.000969	CcSEcCtD
Methylscopolamine bromide—Dizziness—Ifosfamide—hematologic cancer	0.000732	0.000965	CcSEcCtD
Methylscopolamine bromide—Vision blurred—Prednisone—hematologic cancer	0.000724	0.000954	CcSEcCtD
Methylscopolamine bromide—Nausea—Thiotepa—hematologic cancer	0.000723	0.000953	CcSEcCtD
Methylscopolamine bromide—Feeling abnormal—Etoposide—hematologic cancer	0.000721	0.00095	CcSEcCtD
Methylscopolamine bromide—Anaphylactic shock—Betamethasone—hematologic cancer	0.00072	0.000949	CcSEcCtD
Methylscopolamine bromide—Anaphylactic shock—Dexamethasone—hematologic cancer	0.00072	0.000949	CcSEcCtD
Methylscopolamine bromide—Vomiting—Carmustine—hematologic cancer	0.000719	0.000948	CcSEcCtD
Methylscopolamine bromide—Insomnia—Triamcinolone—hematologic cancer	0.000717	0.000946	CcSEcCtD
Methylscopolamine bromide—Dizziness—Vincristine—hematologic cancer	0.000714	0.000941	CcSEcCtD
Methylscopolamine bromide—Vomiting—Alitretinoin—hematologic cancer	0.000712	0.000939	CcSEcCtD
Methylscopolamine bromide—Drowsiness—Doxorubicin—hematologic cancer	0.000711	0.000938	CcSEcCtD
Methylscopolamine bromide—Feeling abnormal—Prednisolone—hematologic cancer	0.000711	0.000937	CcSEcCtD
Methylscopolamine bromide—Headache—Carmustine—hematologic cancer	0.000708	0.000934	CcSEcCtD
Methylscopolamine bromide—Vomiting—Ifosfamide—hematologic cancer	0.000704	0.000928	CcSEcCtD
Methylscopolamine bromide—Hypersensitivity—Cisplatin—hematologic cancer	0.000703	0.000927	CcSEcCtD
Methylscopolamine bromide—Tachycardia—Betamethasone—hematologic cancer	0.000702	0.000926	CcSEcCtD
Methylscopolamine bromide—Tachycardia—Dexamethasone—hematologic cancer	0.000702	0.000926	CcSEcCtD
Methylscopolamine bromide—Headache—Alitretinoin—hematologic cancer	0.000702	0.000925	CcSEcCtD
Methylscopolamine bromide—Nausea—Thalidomide—hematologic cancer	0.000699	0.000922	CcSEcCtD
Methylscopolamine bromide—Dizziness—Irinotecan—hematologic cancer	0.000695	0.000917	CcSEcCtD
Methylscopolamine bromide—Urticaria—Etoposide—hematologic cancer	0.000695	0.000916	CcSEcCtD
Methylscopolamine bromide—Vomiting—Vincristine—hematologic cancer	0.000686	0.000905	CcSEcCtD
Methylscopolamine bromide—Urticaria—Prednisolone—hematologic cancer	0.000685	0.000903	CcSEcCtD
Methylscopolamine bromide—Asthenia—Cisplatin—hematologic cancer	0.000685	0.000903	CcSEcCtD
Methylscopolamine bromide—Headache—Vincristine—hematologic cancer	0.000676	0.000892	CcSEcCtD
Methylscopolamine bromide—Nausea—Carmustine—hematologic cancer	0.000672	0.000886	CcSEcCtD
Methylscopolamine bromide—Vomiting—Mitoxantrone—hematologic cancer	0.000668	0.000881	CcSEcCtD
Methylscopolamine bromide—Vomiting—Irinotecan—hematologic cancer	0.000668	0.000881	CcSEcCtD
Methylscopolamine bromide—Nausea—Alitretinoin—hematologic cancer	0.000665	0.000877	CcSEcCtD
Methylscopolamine bromide—Headache—Irinotecan—hematologic cancer	0.000659	0.000868	CcSEcCtD
Methylscopolamine bromide—Headache—Mitoxantrone—hematologic cancer	0.000659	0.000868	CcSEcCtD
Methylscopolamine bromide—Nausea—Ifosfamide—hematologic cancer	0.000658	0.000867	CcSEcCtD
Methylscopolamine bromide—Feeling abnormal—Triamcinolone—hematologic cancer	0.000654	0.000862	CcSEcCtD
Methylscopolamine bromide—Vomiting—Gemcitabine—hematologic cancer	0.000651	0.000859	CcSEcCtD
Methylscopolamine bromide—Insomnia—Dexamethasone—hematologic cancer	0.000651	0.000858	CcSEcCtD
Methylscopolamine bromide—Insomnia—Betamethasone—hematologic cancer	0.000651	0.000858	CcSEcCtD
Methylscopolamine bromide—Hypersensitivity—Etoposide—hematologic cancer	0.000644	0.00085	CcSEcCtD
Methylscopolamine bromide—Headache—Gemcitabine—hematologic cancer	0.000642	0.000846	CcSEcCtD
Methylscopolamine bromide—Nausea—Vincristine—hematologic cancer	0.000641	0.000845	CcSEcCtD
Methylscopolamine bromide—Hypersensitivity—Prednisolone—hematologic cancer	0.000635	0.000838	CcSEcCtD
Methylscopolamine bromide—Urticaria—Triamcinolone—hematologic cancer	0.00063	0.000831	CcSEcCtD
Methylscopolamine bromide—Asthenia—Etoposide—hematologic cancer	0.000627	0.000827	CcSEcCtD
Methylscopolamine bromide—Anaphylactic shock—Prednisone—hematologic cancer	0.000627	0.000826	CcSEcCtD
Methylscopolamine bromide—Nausea—Mitoxantrone—hematologic cancer	0.000624	0.000823	CcSEcCtD
Methylscopolamine bromide—Nausea—Irinotecan—hematologic cancer	0.000624	0.000823	CcSEcCtD
Methylscopolamine bromide—Tachycardia—Prednisone—hematologic cancer	0.000612	0.000807	CcSEcCtD
Methylscopolamine bromide—Nausea—Gemcitabine—hematologic cancer	0.000608	0.000802	CcSEcCtD
Methylscopolamine bromide—Vomiting—Cisplatin—hematologic cancer	0.000607	0.0008	CcSEcCtD
Methylscopolamine bromide—Vision blurred—Methotrexate—hematologic cancer	0.000605	0.000798	CcSEcCtD
Methylscopolamine bromide—Feeling abnormal—Dexamethasone—hematologic cancer	0.000593	0.000782	CcSEcCtD
Methylscopolamine bromide—Feeling abnormal—Betamethasone—hematologic cancer	0.000593	0.000782	CcSEcCtD
Methylscopolamine bromide—Tension—Epirubicin—hematologic cancer	0.000589	0.000777	CcSEcCtD
Methylscopolamine bromide—Hypersensitivity—Triamcinolone—hematologic cancer	0.000584	0.000771	CcSEcCtD
Methylscopolamine bromide—Nervousness—Epirubicin—hematologic cancer	0.000583	0.000769	CcSEcCtD
Methylscopolamine bromide—Dizziness—Etoposide—hematologic cancer	0.000578	0.000762	CcSEcCtD
Methylscopolamine bromide—Urticaria—Dexamethasone—hematologic cancer	0.000572	0.000754	CcSEcCtD
Methylscopolamine bromide—Urticaria—Betamethasone—hematologic cancer	0.000572	0.000754	CcSEcCtD
Methylscopolamine bromide—Dizziness—Prednisolone—hematologic cancer	0.00057	0.000752	CcSEcCtD
Methylscopolamine bromide—Asthenia—Triamcinolone—hematologic cancer	0.000569	0.00075	CcSEcCtD
Methylscopolamine bromide—Nausea—Cisplatin—hematologic cancer	0.000567	0.000748	CcSEcCtD
Methylscopolamine bromide—Insomnia—Prednisone—hematologic cancer	0.000567	0.000747	CcSEcCtD
Methylscopolamine bromide—Vision blurred—Epirubicin—hematologic cancer	0.000566	0.000746	CcSEcCtD
Methylscopolamine bromide—Vomiting—Etoposide—hematologic cancer	0.000556	0.000733	CcSEcCtD
Methylscopolamine bromide—Headache—Etoposide—hematologic cancer	0.000548	0.000722	CcSEcCtD
Methylscopolamine bromide—Tension—Doxorubicin—hematologic cancer	0.000545	0.000719	CcSEcCtD
Methylscopolamine bromide—Headache—Prednisolone—hematologic cancer	0.00054	0.000712	CcSEcCtD
Methylscopolamine bromide—Nervousness—Doxorubicin—hematologic cancer	0.00054	0.000712	CcSEcCtD
Methylscopolamine bromide—Constipation—Prednisone—hematologic cancer	0.000536	0.000707	CcSEcCtD
Methylscopolamine bromide—Palpitations—Epirubicin—hematologic cancer	0.000531	0.0007	CcSEcCtD
Methylscopolamine bromide—Confusional state—Methotrexate—hematologic cancer	0.000528	0.000696	CcSEcCtD
Methylscopolamine bromide—Dizziness—Triamcinolone—hematologic cancer	0.000525	0.000692	CcSEcCtD
Methylscopolamine bromide—Anaphylactic shock—Methotrexate—hematologic cancer	0.000524	0.000691	CcSEcCtD
Methylscopolamine bromide—Vision blurred—Doxorubicin—hematologic cancer	0.000524	0.000691	CcSEcCtD
Methylscopolamine bromide—Nausea—Etoposide—hematologic cancer	0.000519	0.000685	CcSEcCtD
Methylscopolamine bromide—Feeling abnormal—Prednisone—hematologic cancer	0.000516	0.000681	CcSEcCtD
Methylscopolamine bromide—Asthenia—Dexamethasone—hematologic cancer	0.000516	0.000681	CcSEcCtD
Methylscopolamine bromide—Asthenia—Betamethasone—hematologic cancer	0.000516	0.000681	CcSEcCtD
Methylscopolamine bromide—Nausea—Prednisolone—hematologic cancer	0.000512	0.000676	CcSEcCtD
Methylscopolamine bromide—Vomiting—Triamcinolone—hematologic cancer	0.000504	0.000665	CcSEcCtD
Methylscopolamine bromide—Dry mouth—Epirubicin—hematologic cancer	0.0005	0.000659	CcSEcCtD
Methylscopolamine bromide—Urticaria—Prednisone—hematologic cancer	0.000498	0.000657	CcSEcCtD
Methylscopolamine bromide—Headache—Triamcinolone—hematologic cancer	0.000497	0.000655	CcSEcCtD
Methylscopolamine bromide—Confusional state—Epirubicin—hematologic cancer	0.000494	0.000652	CcSEcCtD
Methylscopolamine bromide—Palpitations—Doxorubicin—hematologic cancer	0.000491	0.000648	CcSEcCtD
Methylscopolamine bromide—Anaphylactic shock—Epirubicin—hematologic cancer	0.00049	0.000646	CcSEcCtD
Methylscopolamine bromide—Tachycardia—Epirubicin—hematologic cancer	0.000478	0.000631	CcSEcCtD
Methylscopolamine bromide—Dizziness—Betamethasone—hematologic cancer	0.000476	0.000628	CcSEcCtD
Methylscopolamine bromide—Dizziness—Dexamethasone—hematologic cancer	0.000476	0.000628	CcSEcCtD
Methylscopolamine bromide—Insomnia—Methotrexate—hematologic cancer	0.000474	0.000625	CcSEcCtD
Methylscopolamine bromide—Nausea—Triamcinolone—hematologic cancer	0.000471	0.000621	CcSEcCtD
Methylscopolamine bromide—Somnolence—Methotrexate—hematologic cancer	0.000466	0.000614	CcSEcCtD
Methylscopolamine bromide—Dry mouth—Doxorubicin—hematologic cancer	0.000463	0.00061	CcSEcCtD
Methylscopolamine bromide—Hypersensitivity—Prednisone—hematologic cancer	0.000462	0.000609	CcSEcCtD
Methylscopolamine bromide—Vomiting—Dexamethasone—hematologic cancer	0.000458	0.000603	CcSEcCtD
Methylscopolamine bromide—Vomiting—Betamethasone—hematologic cancer	0.000458	0.000603	CcSEcCtD
Methylscopolamine bromide—Confusional state—Doxorubicin—hematologic cancer	0.000457	0.000603	CcSEcCtD
Methylscopolamine bromide—Anaphylactic shock—Doxorubicin—hematologic cancer	0.000454	0.000598	CcSEcCtD
Methylscopolamine bromide—Headache—Betamethasone—hematologic cancer	0.000451	0.000594	CcSEcCtD
Methylscopolamine bromide—Headache—Dexamethasone—hematologic cancer	0.000451	0.000594	CcSEcCtD
Methylscopolamine bromide—Asthenia—Prednisone—hematologic cancer	0.00045	0.000593	CcSEcCtD
Methylscopolamine bromide—Insomnia—Epirubicin—hematologic cancer	0.000443	0.000585	CcSEcCtD
Methylscopolamine bromide—Tachycardia—Doxorubicin—hematologic cancer	0.000443	0.000584	CcSEcCtD
Methylscopolamine bromide—Somnolence—Epirubicin—hematologic cancer	0.000436	0.000575	CcSEcCtD
Methylscopolamine bromide—Feeling abnormal—Methotrexate—hematologic cancer	0.000432	0.000569	CcSEcCtD
Methylscopolamine bromide—Nausea—Dexamethasone—hematologic cancer	0.000427	0.000564	CcSEcCtD
Methylscopolamine bromide—Nausea—Betamethasone—hematologic cancer	0.000427	0.000564	CcSEcCtD
Methylscopolamine bromide—Constipation—Epirubicin—hematologic cancer	0.000419	0.000553	CcSEcCtD
Methylscopolamine bromide—Urticaria—Methotrexate—hematologic cancer	0.000416	0.000549	CcSEcCtD
Methylscopolamine bromide—Dizziness—Prednisone—hematologic cancer	0.000414	0.000546	CcSEcCtD
Methylscopolamine bromide—Insomnia—Doxorubicin—hematologic cancer	0.00041	0.000541	CcSEcCtD
Methylscopolamine bromide—Feeling abnormal—Epirubicin—hematologic cancer	0.000404	0.000533	CcSEcCtD
Methylscopolamine bromide—Somnolence—Doxorubicin—hematologic cancer	0.000403	0.000532	CcSEcCtD
Methylscopolamine bromide—Vomiting—Prednisone—hematologic cancer	0.000399	0.000525	CcSEcCtD
Methylscopolamine bromide—Headache—Prednisone—hematologic cancer	0.000393	0.000518	CcSEcCtD
Methylscopolamine bromide—Urticaria—Epirubicin—hematologic cancer	0.000389	0.000513	CcSEcCtD
Methylscopolamine bromide—Constipation—Doxorubicin—hematologic cancer	0.000388	0.000511	CcSEcCtD
Methylscopolamine bromide—Hypersensitivity—Methotrexate—hematologic cancer	0.000386	0.000509	CcSEcCtD
Methylscopolamine bromide—Asthenia—Methotrexate—hematologic cancer	0.000376	0.000496	CcSEcCtD
Methylscopolamine bromide—Feeling abnormal—Doxorubicin—hematologic cancer	0.000374	0.000493	CcSEcCtD
Methylscopolamine bromide—Nausea—Prednisone—hematologic cancer	0.000372	0.000491	CcSEcCtD
Methylscopolamine bromide—Hypersensitivity—Epirubicin—hematologic cancer	0.000361	0.000476	CcSEcCtD
Methylscopolamine bromide—Urticaria—Doxorubicin—hematologic cancer	0.00036	0.000475	CcSEcCtD
Methylscopolamine bromide—Asthenia—Epirubicin—hematologic cancer	0.000352	0.000464	CcSEcCtD
Methylscopolamine bromide—Dizziness—Methotrexate—hematologic cancer	0.000346	0.000457	CcSEcCtD
Methylscopolamine bromide—Hypersensitivity—Doxorubicin—hematologic cancer	0.000334	0.000441	CcSEcCtD
Methylscopolamine bromide—Vomiting—Methotrexate—hematologic cancer	0.000333	0.000439	CcSEcCtD
Methylscopolamine bromide—Headache—Methotrexate—hematologic cancer	0.000328	0.000433	CcSEcCtD
Methylscopolamine bromide—Asthenia—Doxorubicin—hematologic cancer	0.000325	0.000429	CcSEcCtD
Methylscopolamine bromide—Dizziness—Epirubicin—hematologic cancer	0.000324	0.000427	CcSEcCtD
Methylscopolamine bromide—Vomiting—Epirubicin—hematologic cancer	0.000312	0.000411	CcSEcCtD
Methylscopolamine bromide—Nausea—Methotrexate—hematologic cancer	0.000311	0.00041	CcSEcCtD
Methylscopolamine bromide—Headache—Epirubicin—hematologic cancer	0.000307	0.000405	CcSEcCtD
Methylscopolamine bromide—Dizziness—Doxorubicin—hematologic cancer	0.0003	0.000395	CcSEcCtD
Methylscopolamine bromide—Nausea—Epirubicin—hematologic cancer	0.000291	0.000384	CcSEcCtD
Methylscopolamine bromide—Vomiting—Doxorubicin—hematologic cancer	0.000288	0.00038	CcSEcCtD
Methylscopolamine bromide—Headache—Doxorubicin—hematologic cancer	0.000284	0.000375	CcSEcCtD
Methylscopolamine bromide—Nausea—Doxorubicin—hematologic cancer	0.000269	0.000355	CcSEcCtD
Methylscopolamine bromide—CHRM2—Signaling Pathways—FGF1—hematologic cancer	3.8e-05	0.000157	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—Signaling Pathways—CSF2—hematologic cancer	3.8e-05	0.000157	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—Signaling Pathways—FOXO1—hematologic cancer	3.79e-05	0.000157	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—GPCR downstream signaling—IL2—hematologic cancer	3.79e-05	0.000157	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—Signaling Pathways—PDGFRB—hematologic cancer	3.78e-05	0.000157	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Signaling Pathways—FOXO1—hematologic cancer	3.78e-05	0.000156	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—GPCR downstream signaling—IL2—hematologic cancer	3.78e-05	0.000156	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Signaling Pathways—PDGFRB—hematologic cancer	3.77e-05	0.000156	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—Signaling by GPCR—PIK3CB—hematologic cancer	3.75e-05	0.000155	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—Signaling Pathways—FOXO1—hematologic cancer	3.74e-05	0.000155	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—GPCR downstream signaling—IL2—hematologic cancer	3.74e-05	0.000155	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—Signaling Pathways—PDGFRB—hematologic cancer	3.73e-05	0.000155	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Signaling by GPCR—PIK3CB—hematologic cancer	3.73e-05	0.000155	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—Signaling Pathways—PDGFRA—hematologic cancer	3.72e-05	0.000154	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Signaling Pathways—PDGFRA—hematologic cancer	3.71e-05	0.000154	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—Signaling Pathways—PRKCG—hematologic cancer	3.71e-05	0.000154	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—Signaling Pathways—JAK1—hematologic cancer	3.71e-05	0.000154	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Signaling Pathways—PRKCG—hematologic cancer	3.7e-05	0.000153	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Signaling Pathways—JAK1—hematologic cancer	3.7e-05	0.000153	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—Signaling by GPCR—PIK3CB—hematologic cancer	3.7e-05	0.000153	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—Signaling Pathways—PDGFRA—hematologic cancer	3.68e-05	0.000152	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—Signaling Pathways—JAK1—hematologic cancer	3.66e-05	0.000152	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—Signaling Pathways—PRKCG—hematologic cancer	3.66e-05	0.000152	CbGpPWpGaD
Methylscopolamine bromide—CHRM5—Signaling Pathways—MAP2K1—hematologic cancer	3.63e-05	0.00015	CbGpPWpGaD
Methylscopolamine bromide—CHRM5—Signaling Pathways—PIK3CD—hematologic cancer	3.61e-05	0.000149	CbGpPWpGaD
Methylscopolamine bromide—CHRM5—GPCR downstream signaling—PIK3CA—hematologic cancer	3.57e-05	0.000148	CbGpPWpGaD
Methylscopolamine bromide—CHRM5—Signaling by GPCR—KRAS—hematologic cancer	3.53e-05	0.000146	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—Signaling Pathways—IL2RA—hematologic cancer	3.47e-05	0.000144	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Signaling Pathways—IL2RA—hematologic cancer	3.46e-05	0.000143	CbGpPWpGaD
Methylscopolamine bromide—CHRM5—Signaling Pathways—FGF2—hematologic cancer	3.45e-05	0.000143	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Metabolism—PIK3CG—hematologic cancer	3.44e-05	0.000143	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—Signaling by GPCR—IL2—hematologic cancer	3.44e-05	0.000142	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Signaling by GPCR—IL2—hematologic cancer	3.43e-05	0.000142	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—Signaling Pathways—TERT—hematologic cancer	3.43e-05	0.000142	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—Signaling Pathways—IL2RA—hematologic cancer	3.42e-05	0.000142	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Signaling Pathways—TERT—hematologic cancer	3.42e-05	0.000141	CbGpPWpGaD
Methylscopolamine bromide—CHRM5—Signaling Pathways—PIK3R1—hematologic cancer	3.4e-05	0.000141	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—Signaling by GPCR—IL2—hematologic cancer	3.4e-05	0.000141	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—Signaling Pathways—TERT—hematologic cancer	3.38e-05	0.00014	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—Signaling Pathways—PDGFB—hematologic cancer	3.35e-05	0.000138	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Signaling Pathways—PDGFB—hematologic cancer	3.34e-05	0.000138	CbGpPWpGaD
Methylscopolamine bromide—CHRM5—Signaling Pathways—JAK2—hematologic cancer	3.31e-05	0.000137	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—Signaling Pathways—PDGFB—hematologic cancer	3.3e-05	0.000137	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—Signaling Pathways—TSC2—hematologic cancer	3.27e-05	0.000135	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Signaling Pathways—TSC2—hematologic cancer	3.26e-05	0.000135	CbGpPWpGaD
Methylscopolamine bromide—CHRM5—Signaling by GPCR—PIK3CA—hematologic cancer	3.24e-05	0.000134	CbGpPWpGaD
Methylscopolamine bromide—CHRM5—Signaling Pathways—MDM2—hematologic cancer	3.23e-05	0.000134	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—Signaling Pathways—TSC2—hematologic cancer	3.23e-05	0.000134	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Metabolism—CREBBP—hematologic cancer	3.19e-05	0.000132	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—Signaling Pathways—FGFR3—hematologic cancer	3.15e-05	0.00013	CbGpPWpGaD
Methylscopolamine bromide—CHRM5—Signaling Pathways—MTOR—hematologic cancer	3.14e-05	0.00013	CbGpPWpGaD
Methylscopolamine bromide—CHRM5—Signaling Pathways—PIK3CB—hematologic cancer	3.14e-05	0.00013	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Signaling Pathways—FGFR3—hematologic cancer	3.14e-05	0.00013	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—Signaling Pathways—MAPK14—hematologic cancer	3.11e-05	0.000129	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—Signaling Pathways—FGFR3—hematologic cancer	3.11e-05	0.000129	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Signaling Pathways—MAPK14—hematologic cancer	3.1e-05	0.000129	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—Signaling Pathways—MAPK14—hematologic cancer	3.07e-05	0.000127	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—Signaling Pathways—ESR1—hematologic cancer	3.06e-05	0.000126	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Signaling Pathways—ESR1—hematologic cancer	3.05e-05	0.000126	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Metabolism—PIK3CD—hematologic cancer	3.03e-05	0.000125	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—Signaling Pathways—FN1—hematologic cancer	3.02e-05	0.000125	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—Signaling Pathways—ESR1—hematologic cancer	3.02e-05	0.000125	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Signaling Pathways—FN1—hematologic cancer	3.01e-05	0.000125	CbGpPWpGaD
Methylscopolamine bromide—CHRM5—Signaling by GPCR—HRAS—hematologic cancer	3e-05	0.000124	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Metabolism—ALB—hematologic cancer	2.99e-05	0.000124	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—Signaling Pathways—BAD—hematologic cancer	2.98e-05	0.000123	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—Signaling Pathways—NFKBIA—hematologic cancer	2.98e-05	0.000123	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—Signaling Pathways—FN1—hematologic cancer	2.98e-05	0.000123	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Signaling Pathways—BAD—hematologic cancer	2.97e-05	0.000123	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Signaling Pathways—NFKBIA—hematologic cancer	2.97e-05	0.000123	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—Signaling Pathways—NOTCH1—hematologic cancer	2.95e-05	0.000122	CbGpPWpGaD
Methylscopolamine bromide—CHRM5—Signaling Pathways—CDKN1B—hematologic cancer	2.95e-05	0.000122	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Signaling Pathways—NOTCH1—hematologic cancer	2.94e-05	0.000122	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—Signaling Pathways—NFKBIA—hematologic cancer	2.94e-05	0.000122	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—Signaling Pathways—BAD—hematologic cancer	2.94e-05	0.000122	CbGpPWpGaD
Methylscopolamine bromide—CHRM5—GPCR downstream signaling—AKT1—hematologic cancer	2.92e-05	0.000121	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—Signaling Pathways—NOTCH1—hematologic cancer	2.92e-05	0.000121	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—Signaling Pathways—CD80—hematologic cancer	2.89e-05	0.00012	CbGpPWpGaD
Methylscopolamine bromide—CHRM5—Signaling Pathways—CASP3—hematologic cancer	2.89e-05	0.00012	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—Signaling Pathways—PIK3CG—hematologic cancer	2.89e-05	0.00012	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—Signaling Pathways—KIT—hematologic cancer	2.89e-05	0.00012	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—Signaling by GPCR—NRAS—hematologic cancer	2.89e-05	0.00012	CbGpPWpGaD
Methylscopolamine bromide—CHRM5—Signaling Pathways—IL2—hematologic cancer	2.89e-05	0.000119	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Signaling Pathways—CD80—hematologic cancer	2.88e-05	0.000119	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Signaling Pathways—PIK3CG—hematologic cancer	2.88e-05	0.000119	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Signaling Pathways—KIT—hematologic cancer	2.88e-05	0.000119	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Signaling by GPCR—NRAS—hematologic cancer	2.88e-05	0.000119	CbGpPWpGaD
Methylscopolamine bromide—CHRM5—Signaling by GPCR—IL6—hematologic cancer	2.87e-05	0.000119	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Metabolism—PIK3R1—hematologic cancer	2.86e-05	0.000118	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—Signaling Pathways—CD80—hematologic cancer	2.86e-05	0.000118	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—Signaling Pathways—KIT—hematologic cancer	2.85e-05	0.000118	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—Signaling Pathways—PIK3CG—hematologic cancer	2.85e-05	0.000118	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—Signaling by GPCR—NRAS—hematologic cancer	2.85e-05	0.000118	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—Signaling Pathways—PTPN11—hematologic cancer	2.84e-05	0.000117	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Signaling Pathways—PTPN11—hematologic cancer	2.83e-05	0.000117	CbGpPWpGaD
Methylscopolamine bromide—CHRM5—Signaling Pathways—CCND1—hematologic cancer	2.81e-05	0.000116	CbGpPWpGaD
Methylscopolamine bromide—CHRM5—Signaling Pathways—JUN—hematologic cancer	2.81e-05	0.000116	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—Signaling Pathways—PTPN11—hematologic cancer	2.8e-05	0.000116	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—Signaling by GPCR—MAPK3—hematologic cancer	2.77e-05	0.000114	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Signaling by GPCR—MAPK3—hematologic cancer	2.76e-05	0.000114	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—Signaling Pathways—CREB1—hematologic cancer	2.75e-05	0.000114	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Signaling Pathways—CREB1—hematologic cancer	2.74e-05	0.000113	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—Signaling by GPCR—MAPK3—hematologic cancer	2.73e-05	0.000113	CbGpPWpGaD
Methylscopolamine bromide—CHRM5—Signaling Pathways—CDKN1A—hematologic cancer	2.72e-05	0.000113	CbGpPWpGaD
Methylscopolamine bromide—CHRM5—Signaling Pathways—PTEN—hematologic cancer	2.72e-05	0.000112	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—Signaling Pathways—BRAF—hematologic cancer	2.71e-05	0.000112	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—Signaling Pathways—CREB1—hematologic cancer	2.71e-05	0.000112	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Signaling Pathways—BRAF—hematologic cancer	2.71e-05	0.000112	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—Signaling Pathways—CCL2—hematologic cancer	2.69e-05	0.000111	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—Signaling Pathways—IL6R—hematologic cancer	2.68e-05	0.000111	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Signaling Pathways—CCL2—hematologic cancer	2.68e-05	0.000111	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—Signaling Pathways—BRAF—hematologic cancer	2.68e-05	0.000111	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—Signaling Pathways—CREBBP—hematologic cancer	2.68e-05	0.000111	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Signaling Pathways—IL6R—hematologic cancer	2.67e-05	0.000111	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Signaling Pathways—CREBBP—hematologic cancer	2.67e-05	0.00011	CbGpPWpGaD
Methylscopolamine bromide—CHRM5—Signaling Pathways—MAPK8—hematologic cancer	2.66e-05	0.00011	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—Signaling Pathways—CCL2—hematologic cancer	2.66e-05	0.00011	CbGpPWpGaD
Methylscopolamine bromide—CHRM5—Signaling by GPCR—AKT1—hematologic cancer	2.65e-05	0.00011	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—Signaling Pathways—IL6R—hematologic cancer	2.65e-05	0.00011	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—Signaling Pathways—CREBBP—hematologic cancer	2.64e-05	0.000109	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Metabolism—PIK3CB—hematologic cancer	2.64e-05	0.000109	CbGpPWpGaD
Methylscopolamine bromide—CHRM5—Signaling Pathways—EP300—hematologic cancer	2.59e-05	0.000107	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—Signaling Pathways—MAP2K1—hematologic cancer	2.56e-05	0.000106	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Signaling Pathways—MAP2K1—hematologic cancer	2.55e-05	0.000105	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—Signaling Pathways—PIK3CD—hematologic cancer	2.54e-05	0.000105	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Signaling Pathways—PIK3CD—hematologic cancer	2.53e-05	0.000105	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—Signaling Pathways—MAP2K1—hematologic cancer	2.52e-05	0.000104	CbGpPWpGaD
Methylscopolamine bromide—CHRM5—Signaling Pathways—SRC—hematologic cancer	2.52e-05	0.000104	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—GPCR downstream signaling—PIK3CA—hematologic cancer	2.51e-05	0.000104	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—GPCR downstream signaling—PIK3CA—hematologic cancer	2.51e-05	0.000104	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—Signaling Pathways—PIK3CD—hematologic cancer	2.51e-05	0.000104	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—Signaling by GPCR—KRAS—hematologic cancer	2.49e-05	0.000103	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—GPCR downstream signaling—PIK3CA—hematologic cancer	2.48e-05	0.000103	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Signaling by GPCR—KRAS—hematologic cancer	2.48e-05	0.000103	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—Signaling by GPCR—KRAS—hematologic cancer	2.45e-05	0.000102	CbGpPWpGaD
Methylscopolamine bromide—CHRM5—Signaling Pathways—VEGFA—hematologic cancer	2.45e-05	0.000102	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—Signaling Pathways—FGF2—hematologic cancer	2.43e-05	0.000101	CbGpPWpGaD
Methylscopolamine bromide—CHRM5—Signaling Pathways—STAT3—hematologic cancer	2.43e-05	0.000101	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Signaling Pathways—FGF2—hematologic cancer	2.42e-05	0.0001	CbGpPWpGaD
Methylscopolamine bromide—CHRM5—Signaling Pathways—NRAS—hematologic cancer	2.42e-05	0.0001	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—Signaling Pathways—FGF2—hematologic cancer	2.4e-05	9.93e-05	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—Signaling Pathways—PIK3R1—hematologic cancer	2.4e-05	9.92e-05	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Signaling Pathways—PIK3R1—hematologic cancer	2.39e-05	9.89e-05	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—Signaling Pathways—PIK3R1—hematologic cancer	2.37e-05	9.8e-05	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—Signaling Pathways—JAK2—hematologic cancer	2.33e-05	9.65e-05	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Signaling Pathways—JAK2—hematologic cancer	2.32e-05	9.61e-05	CbGpPWpGaD
Methylscopolamine bromide—CHRM5—Signaling Pathways—MAPK3—hematologic cancer	2.32e-05	9.61e-05	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—Signaling Pathways—JAK2—hematologic cancer	2.3e-05	9.52e-05	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—Signaling by GPCR—PIK3CA—hematologic cancer	2.28e-05	9.45e-05	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Metabolism—PTEN—hematologic cancer	2.28e-05	9.44e-05	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Signaling by GPCR—PIK3CA—hematologic cancer	2.28e-05	9.42e-05	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—Signaling Pathways—MDM2—hematologic cancer	2.27e-05	9.42e-05	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Signaling Pathways—MDM2—hematologic cancer	2.27e-05	9.39e-05	CbGpPWpGaD
Methylscopolamine bromide—CHRM5—Signaling Pathways—MYC—hematologic cancer	2.26e-05	9.34e-05	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—Signaling by GPCR—PIK3CA—hematologic cancer	2.25e-05	9.33e-05	CbGpPWpGaD
Methylscopolamine bromide—CHRM5—Signaling Pathways—TGFB1—hematologic cancer	2.25e-05	9.32e-05	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—Signaling Pathways—MDM2—hematologic cancer	2.25e-05	9.29e-05	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—Signaling Pathways—MTOR—hematologic cancer	2.21e-05	9.16e-05	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—Signaling Pathways—PIK3CB—hematologic cancer	2.21e-05	9.16e-05	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Signaling Pathways—MTOR—hematologic cancer	2.21e-05	9.13e-05	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Signaling Pathways—PIK3CB—hematologic cancer	2.21e-05	9.13e-05	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—Signaling Pathways—MTOR—hematologic cancer	2.18e-05	9.04e-05	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—Signaling Pathways—PIK3CB—hematologic cancer	2.18e-05	9.04e-05	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Metabolism—EP300—hematologic cancer	2.17e-05	9e-05	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—Signaling by GPCR—HRAS—hematologic cancer	2.11e-05	8.75e-05	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Signaling by GPCR—HRAS—hematologic cancer	2.11e-05	8.72e-05	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—Signaling by GPCR—HRAS—hematologic cancer	2.09e-05	8.63e-05	CbGpPWpGaD
Methylscopolamine bromide—CHRM5—Signaling Pathways—KRAS—hematologic cancer	2.09e-05	8.63e-05	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—Signaling Pathways—CDKN1B—hematologic cancer	2.08e-05	8.6e-05	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Signaling Pathways—CDKN1B—hematologic cancer	2.07e-05	8.57e-05	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—GPCR downstream signaling—AKT1—hematologic cancer	2.05e-05	8.5e-05	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—Signaling Pathways—CDKN1B—hematologic cancer	2.05e-05	8.49e-05	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—GPCR downstream signaling—AKT1—hematologic cancer	2.05e-05	8.48e-05	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—Signaling Pathways—CASP3—hematologic cancer	2.04e-05	8.43e-05	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—Signaling Pathways—IL2—hematologic cancer	2.03e-05	8.41e-05	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Signaling Pathways—CASP3—hematologic cancer	2.03e-05	8.4e-05	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—GPCR downstream signaling—AKT1—hematologic cancer	2.03e-05	8.39e-05	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Signaling Pathways—IL2—hematologic cancer	2.03e-05	8.39e-05	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—Signaling by GPCR—IL6—hematologic cancer	2.02e-05	8.37e-05	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Signaling by GPCR—IL6—hematologic cancer	2.02e-05	8.34e-05	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—Signaling Pathways—CASP3—hematologic cancer	2.01e-05	8.32e-05	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—Signaling Pathways—IL2—hematologic cancer	2.01e-05	8.3e-05	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—Signaling by GPCR—IL6—hematologic cancer	2e-05	8.26e-05	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—Signaling Pathways—CCND1—hematologic cancer	1.98e-05	8.2e-05	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—Signaling Pathways—JUN—hematologic cancer	1.98e-05	8.18e-05	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Signaling Pathways—CCND1—hematologic cancer	1.97e-05	8.17e-05	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Signaling Pathways—JUN—hematologic cancer	1.97e-05	8.16e-05	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—Signaling Pathways—CCND1—hematologic cancer	1.96e-05	8.1e-05	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—Signaling Pathways—JUN—hematologic cancer	1.95e-05	8.08e-05	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—Signaling Pathways—CDKN1A—hematologic cancer	1.92e-05	7.93e-05	CbGpPWpGaD
Methylscopolamine bromide—CHRM5—Signaling Pathways—PIK3CA—hematologic cancer	1.92e-05	7.93e-05	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—Signaling Pathways—PTEN—hematologic cancer	1.91e-05	7.92e-05	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Signaling Pathways—CDKN1A—hematologic cancer	1.91e-05	7.91e-05	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Signaling Pathways—PTEN—hematologic cancer	1.91e-05	7.89e-05	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—Signaling Pathways—CDKN1A—hematologic cancer	1.89e-05	7.83e-05	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—Signaling Pathways—PTEN—hematologic cancer	1.89e-05	7.81e-05	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—Signaling Pathways—MAPK8—hematologic cancer	1.87e-05	7.74e-05	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—Signaling by GPCR—AKT1—hematologic cancer	1.87e-05	7.72e-05	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Signaling Pathways—MAPK8—hematologic cancer	1.86e-05	7.72e-05	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Signaling by GPCR—AKT1—hematologic cancer	1.86e-05	7.7e-05	CbGpPWpGaD
Methylscopolamine bromide—CHRM5—Signaling Pathways—TP53—hematologic cancer	1.85e-05	7.67e-05	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—Signaling Pathways—MAPK8—hematologic cancer	1.85e-05	7.64e-05	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—Signaling by GPCR—AKT1—hematologic cancer	1.84e-05	7.62e-05	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—Signaling Pathways—EP300—hematologic cancer	1.82e-05	7.55e-05	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Signaling Pathways—EP300—hematologic cancer	1.82e-05	7.52e-05	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—Signaling Pathways—EP300—hematologic cancer	1.8e-05	7.45e-05	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—Signaling Pathways—SRC—hematologic cancer	1.77e-05	7.34e-05	CbGpPWpGaD
Methylscopolamine bromide—CHRM5—Signaling Pathways—HRAS—hematologic cancer	1.77e-05	7.34e-05	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Signaling Pathways—SRC—hematologic cancer	1.77e-05	7.32e-05	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—Signaling Pathways—SRC—hematologic cancer	1.75e-05	7.25e-05	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—Signaling Pathways—VEGFA—hematologic cancer	1.73e-05	7.15e-05	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Signaling Pathways—VEGFA—hematologic cancer	1.72e-05	7.13e-05	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—Signaling Pathways—STAT3—hematologic cancer	1.71e-05	7.08e-05	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—Signaling Pathways—NRAS—hematologic cancer	1.71e-05	7.06e-05	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—Signaling Pathways—VEGFA—hematologic cancer	1.7e-05	7.06e-05	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Signaling Pathways—STAT3—hematologic cancer	1.7e-05	7.06e-05	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Signaling Pathways—NRAS—hematologic cancer	1.7e-05	7.04e-05	CbGpPWpGaD
Methylscopolamine bromide—CHRM5—Signaling Pathways—IL6—hematologic cancer	1.7e-05	7.02e-05	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—Signaling Pathways—STAT3—hematologic cancer	1.69e-05	6.99e-05	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—Signaling Pathways—NRAS—hematologic cancer	1.68e-05	6.97e-05	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—Signaling Pathways—MAPK3—hematologic cancer	1.63e-05	6.76e-05	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Signaling Pathways—MAPK3—hematologic cancer	1.63e-05	6.74e-05	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—Signaling Pathways—MAPK3—hematologic cancer	1.61e-05	6.68e-05	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Metabolism—PIK3CA—hematologic cancer	1.61e-05	6.66e-05	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—Signaling Pathways—MYC—hematologic cancer	1.59e-05	6.58e-05	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—Signaling Pathways—TGFB1—hematologic cancer	1.59e-05	6.56e-05	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Signaling Pathways—MYC—hematologic cancer	1.58e-05	6.56e-05	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Signaling Pathways—TGFB1—hematologic cancer	1.58e-05	6.54e-05	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—Signaling Pathways—MYC—hematologic cancer	1.57e-05	6.49e-05	CbGpPWpGaD
Methylscopolamine bromide—CHRM5—Signaling Pathways—AKT1—hematologic cancer	1.57e-05	6.48e-05	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—Signaling Pathways—TGFB1—hematologic cancer	1.56e-05	6.48e-05	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—Signaling Pathways—KRAS—hematologic cancer	1.47e-05	6.08e-05	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Signaling Pathways—KRAS—hematologic cancer	1.46e-05	6.06e-05	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—Signaling Pathways—KRAS—hematologic cancer	1.45e-05	6e-05	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—Signaling Pathways—PIK3CA—hematologic cancer	1.35e-05	5.58e-05	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Signaling Pathways—PIK3CA—hematologic cancer	1.34e-05	5.57e-05	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—Signaling Pathways—PIK3CA—hematologic cancer	1.33e-05	5.51e-05	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Metabolism—AKT1—hematologic cancer	1.31e-05	5.44e-05	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—Signaling Pathways—TP53—hematologic cancer	1.31e-05	5.4e-05	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Signaling Pathways—TP53—hematologic cancer	1.3e-05	5.39e-05	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—Signaling Pathways—TP53—hematologic cancer	1.29e-05	5.33e-05	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—Signaling Pathways—HRAS—hematologic cancer	1.25e-05	5.17e-05	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Signaling Pathways—HRAS—hematologic cancer	1.24e-05	5.15e-05	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—Signaling Pathways—HRAS—hematologic cancer	1.23e-05	5.1e-05	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—Signaling Pathways—IL6—hematologic cancer	1.19e-05	4.94e-05	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Signaling Pathways—IL6—hematologic cancer	1.19e-05	4.93e-05	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—Signaling Pathways—IL6—hematologic cancer	1.18e-05	4.88e-05	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—Signaling Pathways—AKT1—hematologic cancer	1.1e-05	4.56e-05	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Signaling Pathways—AKT1—hematologic cancer	1.1e-05	4.55e-05	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—Signaling Pathways—AKT1—hematologic cancer	1.09e-05	4.5e-05	CbGpPWpGaD
